Favorable intermediate risk prostate cancer with biopsy Gleason score of 6

被引：0
作者：
Jong Jin Oh
Hyungwoo Ahn
Sung Il Hwang
Hak Jong Lee
Gheeyoung Choe
Sangchul Lee
Hakmin Lee
Seok-Soo Byun
Sung Kyu Hong
机构：
[1] Seoul National University Bundang Hospital,Department of Urology
[2] Seoul National University College of Medicine,Department of Urology
[3] Seoul National University Bundang Hospital,Department of Radiology
[4] Seoul National University College of Medicine,Department of Radiology
[5] Seoul National University Bundang Hospital,Department of Pathology
来源：
BMC Urology | / 21卷
关键词：
Prostate cancer; Intermediate risk group; MRI;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Adverse Pathological Findings in Needle Biopsy Gleason Score 6 Prostate Cancers with Low and Intermediate Preoperative PSA Levels Following Radical Prostatectomy
    Heidegger, Isabel
    Ladurner, Michael
    Skradski, Viktor
    Klocker, Helmut
    Schaefer, Georg
    Horninger, Wolfgang
    Bektic, Jasmin
    ANTICANCER RESEARCH, 2012, 32 (12) : 5481 - 5485
  • [22] Mortality Risk for Patients with Biopsy Gleason Grade Group 1 Prostate Cancer
    Tilki, Derya
    Chen, Ming-Hui
    Huland, Hartwig
    Graefen, Markus
    D'Amico, Anthony V.
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (06): : 1520 - 1526
  • [23] Extended 12-core prostate biopsy increases both the detection of prostate cancer and the accuracy of Gleason score
    Elabbady, AA
    Khedr, MM
    EUROPEAN UROLOGY, 2006, 49 (01) : 49 - 53
  • [24] Metabolic Syndrome Is Associated With High Grade Gleason Score When Prostate Cancer Is Diagnosed on Biopsy
    De Nunzio, Cosimo
    Freedland, Stephen J.
    Miano, Roberto
    Trucchi, Alberto
    Cantiani, Andrea
    Carluccini, Alfonso
    Tubaro, Andrea
    PROSTATE, 2011, 71 (14) : 1492 - 1498
  • [25] Predictors of Gleason score upgrading in patients with a biopsy diagnosis of grade group 1 prostate cancer
    Esen, Baris
    Gurses, Bengi
    Ozkan, Arif
    Kilic, Mert
    Kordan, Yakup
    Esen, Tarik
    Baydar, Dilek E. R. T. O. Y.
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2025, 55 (01) : 231 - 236
  • [26] Role of PI-RADS Version 2 for Prediction of Upgrading in Biopsy-Proven Prostate Cancer With Gleason Score 6
    Song, Wan
    Bang, Seok Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Choi, Han Yong
    Kim, Chan Kyo
    Lee, Hyun Moo
    CLINICAL GENITOURINARY CANCER, 2018, 16 (04) : 281 - 287
  • [27] Prognostic parameters other than Gleason score for the daily evaluation of prostate cancer in needle biopsy
    Algaba, F
    Arce, Y
    Oliver, A
    Barandica, C
    Santaularia, JM
    Montañés, R
    EUROPEAN UROLOGY, 2005, 48 (04) : 566 - 571
  • [28] Improved accuracy for predicting the gleason score of prostate cancer by increasing the number of transrectal biopsy cores
    Miyake, Hideaki
    Kurahashi, Toshifumi
    Takenaka, Atsushi
    Hara, Isao
    Fujisawa, Masato
    UROLOGIA INTERNATIONALIS, 2007, 79 (04) : 302 - 306
  • [29] Prostate cancer detection rate and Gleason score in relation to prostate volume as assessed by magnetic resonance imaging cognitive biopsy and standard biopsy
    Nepal, Sat Prasad
    Nakasato, Takehiko
    Ogawa, Yoshio
    Naoe, Michio
    Shichijo, Takeshi
    Maeda, Yoshiko
    Morita, Jun
    Oshinomi, Kazuhiko
    Unoki, Tsutomu
    Inoue, Tatsuki
    Kato, Ryosuke
    Omizu, Madoka
    TURKISH JOURNAL OF UROLOGY, 2020, 46 (06): : 449 - 454
  • [30] A biopsy-integrated algorithm for determining Gleason 6 upgrading risk stratifies risk of active surveillance failure in prostate cancer
    M. L. Blute
    J. M. Shiau
    M. Truong
    Fangfang Shi
    E. J. Abel
    T. M. Downs
    D. F. Jarrard
    World Journal of Urology, 2017, 35 : 729 - 735
12345